Mumbai, Birmingham, March 11, 2024: Global pharma major Lupin Limited (Lupin) joined forces with Birmingham City University, UK (BCU) and hosted a convocation ceremony on March 9, 2024, honouring Indian healthcare professionals who completed the Master’s programme in Advancing Diabetes Care. This ground-breaking course is tailored to empower healthcare professionals with specialized skills and techniques to provide enhanced care for people living with diabetes.

Under the distinguished patronage of Mr. Harjinder Singh Kang, the British Deputy High Commissioner for West India, Professor Wasim Hanif, Medical Director for Advancing Diabetes Care, BCU and Mr. Rajeev Sibal, President – India Regions Formulations, Lupin, the ceremony attracted a gathering of eminent delegates and dignitaries from BCU. Among the esteemed attendees were:

• Professor Maxine Lintern, Deputy Dean – Health & Life Sciences
• David Waters, Head of Internationalization
• Claire J Roberts, Head of Department
• Professor Anne Phillips, Programme Lead for Advancing Diabetes Care
• Martha Stewart, Deputy Programme Lead for Advancing Diabetes Care
• Jayne Robbie, Senior Lecturer in Advancing Diabetes Care & Peripheral Vascular Disease

The Advancing Diabetes Care programme is an exclusive online course to further research and development, equipping healthcare professionals with a profound understanding of the intricacies associated with diabetes management. By fostering customized self-management practices, the programme empowers healthcare professionals, from GPs to pharmacists, to provide optimal patient care. Launched in 2020 as an academic partnership between Lupin and BCU, this initiative addresses the escalating prevalence of diabetes in India.

Mr. Rajeev Sibal, President India Region Formulations, Lupin said, “Lupin remains committed to fostering a culture of academic upskilling and skill enhancement among our clinicians. International partnerships such as our collaboration with Birmingham City University ensure our clinicians receive advanced training and expertise, staying abreast of the latest medical developments. This elevates the standard of care and ensures the implementation of global best practices in India, thereby enhancing healthcare outcomes for our people.”

Speaking at the convocation, Mr. Harjinder Singh Kang, the British Deputy High Commissioner for West India, said, “It is an honour to represent the British Deputy High Commission in Mumbai and a privilege to witness the culmination of this incredible partnership between Lupin and Birmingham City University. The program sets an example of how education is delivered beyond boundaries and how technology is used to advance healthcare in a very impactful manner. I’m excited about the future of the UK-India relationship as we strengthen our ties and forge new partnerships in India.”

Professor Wasim Hanif, Medical Director for Advancing Diabetes Care, Birmingham City University, said, “The Advancing Diabetes Course at the Birmingham City University was set up primarily to rise to this challenge of diabetes across India and upskill health care professionals globally with advanced evidence-based practice. What we have achieved in India since the launch of the course is stupendous. Our students graduating with a prestigious post-graduate qualification is a source of great pride for all of us in the team for the Advancing Diabetes Course at Birmingham City University.”

About Lupin

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The Company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

The Company enjoys a leadership position in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and women’s health areas. Lupin is the third-largest pharmaceutical company in the U.S. by prescriptions. The company invested 7.9% of its revenue in research and development in FY23.

Lupin has 15 manufacturing sites, 7 research centers, more than 20,000 professionals working globally, and has been consistently recognized as a ‘Great Place to Work’ in the Biotechnology & Pharmaceuticals sector.

Please visit www.lupin.com for more information.

Follow us on:

Twitter: https://twitter.com/LupinGlobal

LinkedIn: https://www.linkedin.com/company/lupin

Facebook: http://www.facebook.com/LupinWorld/

About Birmingham City University

Birmingham City University is an international University with 31,000 students from 100 countries studying with us. The University offers bespoke courses and holds the national school of Jewelry dating back to 1888. This school is the largest in Europe for jewelry making. BCU also hosts the Birmingham Conservatoire. BCU has the Defense School of Health Care Studies and is the sole provider for Defense Medical Services in the UK. The Advancing Diabetes Care Programme is the first of its kind and has gained international recognition for its transformation of students and advancement of their individualized person centered diabetes care practices.

Follow us on:

Twitter: https://twitter.com/BCU_PostQual

Webpage: https://www.bcu.ac.uk/courses/diabetes-care-msc-2024-25

For further information or queries, please contact –

Heena Dhedhi
Deputy General Manager – Corporate Communications
Email: heenadhedhi@lupin.com